Is Levodopa the standard medication, i.e. does everyone start with a certain number of tablets and then the dose is simply increased regardless of body weight? How is follow-up carried out? Is it only by telephone, even if the doctor and patient have never met? And is there only one neurologist specialising in Parkinson’s at the Academic Specialist Centre for Neurology? – I would be grateful for a reply.

It is not possible to provide more than a general answer.

All anti-Parkinson’s medication needs to be individually tailored and monitored. There is general advice on how medication can be started at different stages of the disease, and this depends, among other things, on age and other medical conditions, but also on the symptoms present. L-dopa dosages are not, in principle, based on body weight – there is a significant difference in how the medication is absorbed and distributed, and this has little or nothing to do with body weight (it is more related to the ratio of fat to muscle, but also to diet and other medications).

When starting medication, it is necessary to monitor the effect and assess how the course of treatment has progressed. Usually, this is easiest and most effective via telephone follow-up. It is common for this to be carried out by different people (e.g. the doctor who prescribes and a specialist nurse who follows up). A patient should be able to convey information about the effects in a way that experienced healthcare staff can interpret and assess. If it is not possible to understand what a patient is communicating, a follow-up visit may be necessary, but this will naturally prolong the process as it is more time-consuming for both the patient

//Håkan Widner